Clinical analysis of metaplastic breast carcinoma with distant metastases: A multi‑centre experience.

chemotherapy metaplastic breast cancer metastasis overall survival systemic treatment

Journal

Oncology letters
ISSN: 1792-1082
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
May 2024
Historique:
received: 20 12 2023
accepted: 09 02 2024
medline: 22 3 2024
pubmed: 22 3 2024
entrez: 22 3 2024
Statut: epublish

Résumé

Metaplastic breast cancer (BC-Mp), which includes a range of epithelial and mixed epithelial-mesenchymal tumours, are rare malignancies with an unfavourable prognosis. The limited literature on BC-Mp focuses mainly on retrospective data for radically treated patients. Notably absent are studies dedicated to the palliative treatment of BC-Mp with distant metastases. The present retrospective study investigated treatment modalities and prognosis in a multi-centre cohort of 31 female participants diagnosed with distant metastatic BC-Mp, including 7 patients with

Identifiants

DOI: 10.3892/ol.2024.14331 PMID: 38516685 PMC: PMC10955678
pubmed: 38516685
doi: 10.3892/ol.2024.14331
pii: OL-27-5-14331
pmc: PMC10955678
doi:

Types de publication

Journal Article

Langues

eng

Pagination

198

Informations de copyright

Copyright: © 2024 Püsküllüoğlu et al.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Auteurs

Mirosława Püsküllüoğlu (M)

Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 31-115 Krakow, Poland.

Katarzyna Swiderska (K)

Breast Cancer Unit, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.

Aleksandra Konieczna (A)

Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, 02-781 Warsaw, Poland.

Joanna Streb (J)

Department of Oncology, Jagiellonian University Medical College, 31-008 Krakow, Poland.
Department of Oncology, University Hospital, 30-688 Krakow, Poland.

Aleksandra Grela-Wojewoda (A)

Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 31-115 Krakow, Poland.

Agnieszka Rudzinska (A)

Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 31-115 Krakow, Poland.

Jolanta Dobrzańska (J)

Department of Oncology, University Hospital, 30-688 Krakow, Poland.

Renata Pacholczak-Madej (R)

Department of Anatomy, Jagiellonian University Medical College, 31-008 Krakow, Poland.
Department of Gynaecological Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 31-115 Krakow, Poland.
Department of Chemotherapy, The District Hospital, 34-200 Sucha Beskidzka, Poland.

Anna Mucha-Malecka (A)

Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 31-115 Krakow, Poland.

Michał Kunkiel (M)

Department of Breast Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, 02-781 Warsaw, Poland.

Jerzy W Mitus (JW)

Department of Anatomy, Jagiellonian University Medical College, 31-008 Krakow, Poland.
Department of Surgical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 31-115 Krakow, Poland.

Michał Jarząb (M)

Breast Cancer Unit, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.

Marek Ziobro (M)

Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, 31-115 Krakow, Poland.

Classifications MeSH